Skip to Content

GPI S1 (Docusate Sodium 100 mg)

Pill with imprint GPI S1 is White, Round and has been identified as Docusate Sodium 100 mg. It is supplied by Gemini Pharmaceuticals, Inc..

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GPI S1

Docusate Sodium

Imprint:
GPI S1
Strength:
100 mg
Color:
White
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Laxatives
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gemini Pharmaceuticals, Inc.
National Drug Code (NDC):
51645-0750

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide